The UK market has recently experienced some turbulence, with the FTSE 100 index closing lower due to weak trade data from China, highlighting global economic challenges and affecting companies tied to Chinese fortunes. In this environment, identifying high growth tech stocks in the United Kingdom involves looking for companies that demonstrate resilience and innovation despite broader market pressures, offering potential opportunities for growth even when traditional sectors face headwinds.
Top 10 High Growth Tech Companies In The United Kingdom
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Audioboom Group | 8.84% | 59.33% | ★★★★★☆ |
YouGov | 4.12% | 64.42% | ★★★★★☆ |
Redcentric | 5.32% | 67.90% | ★★★★★☆ |
Oxford Biomedica | 16.80% | 80.47% | ★★★★★☆ |
Windar Photonics | 37.17% | 46.73% | ★★★★★☆ |
Quantum Base Holdings | 132.55% | 92.87% | ★★★★★☆ |
Trustpilot Group | 15.02% | 40.20% | ★★★★★☆ |
Faron Pharmaceuticals Oy | 55.41% | 56.79% | ★★★★★☆ |
Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Cordel Group | 33.50% | 148.58% | ★★★★★☆ |
Click here to see the full list of 41 stocks from our UK High Growth Tech and AI Stocks screener.
We'll examine a selection from our screener results.
Genus (LSE:GNS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations across North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market cap of approximately £1.35 billion.
Operations: Genus plc generates revenue primarily from its two main segments: Genus ABS, which accounts for £311.10 million, and Genus PIC, contributing £358 million. The company operates globally across various regions including North America, Latin America, and Asia.
Genus, while not currently profitable, is poised for significant transitions with expected earnings growth of 46.67% annually and revenue increases at 3.9% per year, outpacing the UK market's 3.7%. The recent FDA approval for its PRP gene edit marks a pivotal advancement in the U.S. food supply chain, potentially boosting future revenues as commercialization progresses in key international markets. Additionally, the strategic appointment of Andy Russell as CFO could enhance financial strategies ahead of its profitability forecast within three years, aligning with Genus's growth trajectory in biotechnology amidst challenging industry comparisons due to current unprofitability.
- Navigate through the intricacies of Genus with our comprehensive health report here.
Explore historical data to track Genus' performance over time in our Past section.
Kainos Group (LSE:KNOS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kainos Group plc provides digital technology services across the United Kingdom, Ireland, North America, Central Europe, and internationally with a market capitalization of £898.57 million.
Operations: Kainos Group focuses on delivering digital technology services, generating revenue primarily from its operations in the UK, Ireland, North America, and Central Europe. The company emphasizes a streamlined cost structure to enhance operational efficiency.
Kainos Group, a UK-based tech firm, demonstrates resilience with its strategic share repurchase program, having recently completed a buyback of 3.993 million shares for £30 million. While the company's revenue dipped to £367.25 million from £382.39 million year-over-year, its commitment to shareholder value is evident in the proposed dividend of 19.1 pence per share and an aggressive earnings forecast projecting growth at 16.9% annually—outpacing the UK market average of 14.5%. These initiatives reflect Kainos's adaptability in a fluctuating tech landscape and its potential to sustain growth amidst challenging conditions.
- Get an in-depth perspective on Kainos Group's performance by reading our health report here.
Examine Kainos Group's past performance report to understand how it has performed in the past.
Trustpilot Group (LSE:TRST)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Trustpilot Group plc operates an online review platform connecting businesses and consumers globally, with a market cap of £976.83 million.
Operations: The company generates revenue of $210.75 million through its online review platform, primarily serving as an Internet Information Provider across the United Kingdom, North America, Europe, and other international markets.
With a robust 15% annual revenue growth and an impressive 40.2% forecast in earnings growth, Trustpilot Group stands out in the UK tech sector. The company's recent introduction of innovative features that leverage customer feedback to enhance business strategies highlights its commitment to integrating cutting-edge technology with user experience. These developments not only aim to boost conversion rates but also solidify customer loyalty, underpinning Trustpilot's strategy to transform trust into tangible business outcomes. At its recent AGM, the focus on expanding directorial oversight and refining audit processes further underscores its strategic intent to fortify governance and drive sustained growth.
- Click here and access our complete health analysis report to understand the dynamics of Trustpilot Group.
Understand Trustpilot Group's track record by examining our Past report.
Key Takeaways
- Embark on your investment journey to our 41 UK High Growth Tech and AI Stocks selection here.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Trustpilot Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com